RPL41P5

Across TCGA pan-cancer cohorts, RPL41P5 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPL41P5 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL41P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL41P5 expression acts as an unfavorable survival marker, although some lineages such as BRCA and COAD show a favorable association.

ACC, UCEC, and BRCA are the cancer types where RPL41P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.241	0.640	<.001	113	view →
UCEC	DFS	Median	All	0.788	0.880	.001	38	view →
BRCA	DFS	Tertile	II,III,IV	0.966	0.901	<.001	37	view →
COAD	OS	Quartile	All	0.868	0.352	.001	33	view →
READ	DFS	Quartile	II,III,IV	1.000	0.728	.011	23	view →
KIRP	DFS	Quartile	III,IV	0.370	0.817	.002	22	view →
PRAD	DFS	Median	All	0.903	0.963	<.001	18	view →
KIRC	DFS	Quartile	IV	0.299	0.615	.017	14	view →
DLBC	DFS	Tertile	II,III,IV	1.000	0.422	.022	11	view →
UVM	DFS	Tertile	All	0.780	0.468	.016	10	view →
THYM	DFS	Median	All	0.914	0.550	.012	10	view →
STAD	OS	Quartile	III,IV	0.233	0.655	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPL41P5–ACC (DFS)

Open the ACC breakdown →